Trump says he’s considering pulling U.S. out of ‘paper tiger’ NATO
The President’s comments are the latest threat to America’s allies after their reluctance to help reopen the Strait of Hormuz.
Novo Nordisk shares rise after Wegovy recommended by Britain’s drug price regulator
The new recommendation will significantly expand access to Wegovy on the England’s NHS.
Baidu robotaxis reportedly halted mid-traffic causing crashes in Wuhan, China
Baidu’s Apollo Go robotaxis stopped mid-traffic in a Chinese city on Tuesday, leading to at least one highway collision, according to social media.
Iran threatens Nvidia, Apple and other tech giants with attack
Iran’s Islamic Revolutionary Guard Corps (IRGC) has warned a number of tech companies with Middle East operations they’ll be considered “legitimate targets.”
Europe stocks set for strong rebound as Trump says Iran war will end in weeks
Post Content
Unilever’s $16 billion move shows a shift is happening in consumer products
The tie-up between Unilever and McCormick highlights a shift in strategy among consumer goods companies that prioritizes dominating specific categories
Stocks, bonds and commodities: How global markets have traded the Iran war
Assets across the board have been turbulent in the month since the war began.
Large Japanese companies are more optimistic despite Iran conflict, but analysts say this may not last
The positive sentiment may not fully capture the impact from the Iran war, analysts said, as Japan’s Tankan survey period ended in March.
IndiGo shares jump 8% after India’s largest airline names industry veteran William Walsh as CEO
Walsh, 64, is currently the director general of the International Air Transport Association and will join the Indian airline in early August.
How Ireland became dependent on big pharma — and the risks ahead
In just 50 years, Ireland has become the world’s third largest exporter of pharmaceuticals, with medicines now making up about 20% of Ireland’s GDP. So how did Ireland become so tied to the pharma industry — and is that reliance at risk amid tariffs, patent cliffs and geopolitical tension?